Peptidases have often been proposed as potential drug targets for the development of therapeutics for schistosomiasis because of their involvement in critical cellular processes (36), such as the proteolytic invasion machinery of cercariae that enable them to infect their mammalian hosts (37, 38). The gene discussed is LAP3; the disease is schistosomiasis.